Biocon Biologics to get Rs 225 cr from Tata Capital Growth Fund for 0.85 per cent equity stake Read more
Biocon’s partner Mylan receives favourable ruling from US PTAB on Sanofi’s four device patents for Lantus SoloSTAR Read more